{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:20:27Z","timestamp":1722835227397},"reference-count":19,"publisher":"Frontiers Media SA","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2526,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1111\/j.1432-2277.2008.00703.x","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T08:59:32Z","timestamp":1212656372000},"page":"936-941","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of the risk of viral infection between the living and nonliving musculoskeletal tissue donors in Australia"],"prefix":"10.3389","volume":"21","author":[{"given":"Felix","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Seed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Farrugia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","reference":[{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1423-0410.2006.00777.x","article-title":"Comparison of prevalence rates of microbiological markers between bone\/tissue donations and new blood donors in Scotland","volume":"91","author":"Galea","year":"2006","journal-title":"Vox Sang"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB2","volume-title":"Code of Good Manufacturing Practice - Human Blood and Tissues","author":"Australian Therapeutic Goods Administration","year":"2000"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB3","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1111\/j.1600-6143.2007.02012.x","article-title":"The risk of HIV, HBV, HCV, and HTLV infection among musculoskeletal tissue donors in Australia","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1445-5994.2005.00926.x","article-title":"Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and human T lymphotrophic virus","volume":"35","author":"Seed","year":"2005","journal-title":"Intern Med J"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1046\/j.1537-2995.2002.00204.x","article-title":"Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT","volume":"42","author":"Seed","year":"2002","journal-title":"Transfusion"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1537-2995.2002.00200.x","article-title":"International application of the incidence rate\/window period model","volume":"42","author":"Glynn","year":"2002","journal-title":"Transfusion"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/tmrv.1997.0110155","article-title":"The incidence\/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection","volume":"11","author":"Kleinman","year":"1997","journal-title":"Transfus Med Rev"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1423-0410.2005.00636_1.x","article-title":"Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003","volume":"88","author":"Coste","year":"2005","journal-title":"Vox Sang"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1537-2995.2003.00392.x","article-title":"The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations","volume":"46","author":"Jackson","year":"2003","journal-title":"Transfusion"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB12","volume-title":"Bank Activities","author":"Transplantation Society of Australia and New Zealand","year":"20022004"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1995.35295125745.x","article-title":"Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB14","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1386-6532(06)80005-3","article-title":"Assessing the impact of HBV NAT on window period reduction and residual risk","volume":"36","author":"Kleinman","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1246-7820(98)85001-5","article-title":"Prevalence of HIV, HTLV and hepatitis B and C viruses in blood donors in France 1992-1996","volume":"5","author":"Pillonel","year":"1998","journal-title":"Transfus Clin Biol"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.2910510609","article-title":"A prospective study of transmission by transfusion of HTLV-1 and risk factors associated with seroconversion","volume":"51","author":"Manns","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.0041-1132.2004.04153.x","article-title":"Patterns of age- and sex-specific prevalence of major blood-borne infections in the United States blood donors, 1995 to 2002: American Red Cross blood donor study","volume":"44","author":"Zou","year":"2004","journal-title":"Transfusion"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(04)17315-7","article-title":"HIV and hepatitis C virus RNA in seronegative organ and tissue donors","volume":"364","author":"Challine","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2008.00703.x-BIB19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJMoa032510","article-title":"Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States","volume":"351","author":"Zou","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2008.00703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2008.00703.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:36:19Z","timestamp":1641062179000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2008.00703.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00703.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"value":"0934-0874","type":"print"},{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}